Larvol Delta - BlossomHill-Therapeutics-to-Present-Preliminary-Results-From-Phase-1-Dose-EscalationBackll-Cohorts-in-Phase-12-SOLARA-Trial-of-OMNIEGFR-Inhibitor-BH30643-in-Advanced-EGFRmutant-NSCLC-at-the-2026-ASCO-Annual-Meeting

BH-30643 - BlossomHill Therap

https://www.globenewswire.com/news-release/2026/05/21/3299782/0/en/BlossomHill-Therapeutics-to-Present-Preliminary-Results-From-Phase-1-Dose-Escalation-Backfill-Cohorts-in-Phase-1-2-SOLARA-Trial-of-OMNI-EGFR-Inhibitor-BH-30643-in-Advanced-EGFR-mut.html

May 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next